Nuzenio

Moomoo Recursion Pharmaceuticals

Moomoo Recursion Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Sat, 08 Aug 2026 00:33:02 GMTRecursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Fri, 07 Aug 2026 14:49:17 GMTRecursion Pharmaceuticals | SCHEDULE 13G: Others - Moomoo

Fri, 07 Aug 2026 14:41:30 GMTBofA Securities Maintains Recursion Pharmaceuticals(RXRX.US) With Hold Rating, Maintains Target Price $6 - Moomoo

Wed, 05 Aug 2026 14:44:55 GMTRecursion Pharmaceuticals Shares Fall After Q2 Miss - Moomoo

Wed, 05 Aug 2026 11:44:20 GMTRecursion Pharmaceuticals Shares Fall 9% Prem - Moomoo

Mon, 03 Aug 2026 16:14:55 GMT$Recursion Pharmaceuticals (RXRX.US)$ - Moomoo

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Moomoo Recursion Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.